|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
| |
 |
| Nuvelo, Inc. (NUVO) |
OBP II |
(Formerly Variagenics, Inc.; Acquired by HYSEQ Pharmaceuticals, Inc. to form new company, Nuvelo, Inc.)
Sunnyvale, CA
www.nuvelo.com
Nuvelo exists to optimize therapeutic outcomes for patients and their prescribing physicians by applying
pharmacogenomics, or the understanding of the influence of genetic variation on drug response, to the
development of drugs and related diagnostics.
|
|
| |
|
|
|
|
|
